Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema.
Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD, Ferris FL, Huang SS, Kaiser PK, Kollman C, Sadda S, Scott IU, Qin H; Diabetic Retinopathy Clinical Research Network. Browning DJ, et al. Ophthalmology. 2008 Aug;115(8):1366-71, 1371.e1. doi: 10.1016/j.ophtha.2007.12.004. Ophthalmology. 2008. PMID: 18675696 Free PMC article.
A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration.
Nguyen QD, Shah SM, Browning DJ, Hudson H, Sonkin P, Hariprasad SM, Kaiser P, Slakter JS, Haller J, Do DV, Mieler WF, Chu K, Yang K, Ingerman A, Vitti RL, Berliner AJ, Cedarbaum JM, Campochiaro PA. Nguyen QD, et al. Among authors: do dv. Ophthalmology. 2009 Nov;116(11):2141-8.e1. doi: 10.1016/j.ophtha.2009.04.030. Epub 2009 Aug 22. Ophthalmology. 2009. PMID: 19700196 Clinical Trial.
RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027.
Kaiser PK, Symons RC, Shah SM, Quinlan EJ, Tabandeh H, Do DV, Reisen G, Lockridge JA, Short B, Guerciolini R, Nguyen QD; Sirna-027 Study Investigators. Kaiser PK, et al. Among authors: do dv. Am J Ophthalmol. 2010 Jul;150(1):33-39.e2. doi: 10.1016/j.ajo.2010.02.006. Am J Ophthalmol. 2010. PMID: 20609706 Clinical Trial.
Diagnostic and therapeutic challenges.
Hatef E, Ibrahim M, Nguyen QD, Do DV, Davis MJ, Rezaei KA, Kovach JL. Hatef E, et al. Among authors: do dv. Retina. 2011 Jun;31(6):1218-23. doi: 10.1097/IAE.0b013e31820a675a. Retina. 2011. PMID: 21386757 No abstract available.
Evaluation of very high- and very low-dose intravitreal aflibercept in patients with neovascular age-related macular degeneration.
Nguyen QD, Campochiaro PA, Shah SM, Browning DJ, Hudson HL, Sonkin PL, Hariprasad SM, Kaiser PK, Slakter J, Haller JA, Do DV, Mieler W, Chu K, Ingerman A, Vitti R, Berliner AJ, Cedarbaum J; Clear-It 1 Investigators. Nguyen QD, et al. Among authors: do dv. J Ocul Pharmacol Ther. 2012 Dec;28(6):581-8. doi: 10.1089/jop.2011.0261. Epub 2012 Jul 9. J Ocul Pharmacol Ther. 2012. PMID: 22775078 Clinical Trial.
Putting theories and results into practice: managing cases.
Nguyen QD, Do DV, Haller JA, Heier JS, Kaiser PK. Nguyen QD, et al. Among authors: do dv. Ophthalmology. 2013 May;120(5 Suppl):S16-22. doi: 10.1016/j.ophtha.2013.01.060. Ophthalmology. 2013. PMID: 23642782
300 results